SCHEMBL5480161

SCHEMBL5480161

CCc1ccccc1Nc1c2c(nc3ccccc13)CCC2

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 7/20 0.67
SMN1; SMN2 Q16637 6/20 0.67
KMT2A Q03164 5/20 0.67
MEN1 O00255 4/20 0.67
POLB P06746 2/20 0.59
NPSR1 Q6W5P4 2/20 0.59
GFER P55789 2/20 0.57
NPC1 O15118 1/20 0.57
ATM Q13315 1/20 0.57
HTT P42858 2/20 0.57
LMNA P02545 1/20 0.57
GAA P10253 1/20 0.57
BCHE P06276 3/20 0.56
ACHE P22303 3/20 0.56
MAPT P10636 3/20 0.55
KDM4E B2RXH2 1/20 0.55
PABPC1 P11940 1/20 0.55
EIF4H Q15056 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13692586 0.81 KDM1A (0.58) SMN1; SMN2KMT2AMEN1POLBNPSR1
SCHEMBL5470535 0.80 KMT2A (1.00) TP53SMN1; SMN2KMT2AMEN1POLB
SCHEMBL12552069 0.76 ACHE (0.73) BCHEACHE
SCHEMBL29522722 0.74 ACHE (0.66) KMT2ABCHEACHE
SCHEMBL7935344 0.74 KMT2A (0.68) TP53SMN1; SMN2KMT2AMEN1POLB
SCHEMBL16684277 0.74 ACHE (0.66) KMT2ABCHEACHE
SCHEMBL9748781 0.73 KDM4E (0.68) KMT2AMEN1HTTGAABCHE
SCHEMBL8004824 0.73 KMT2A (0.64) TP53SMN1; SMN2KMT2AMEN1POLB
SCHEMBL17124047 0.73 ACHE (0.61) KMT2AATMBCHEACHE
SCHEMBL9208663 0.73 HTT (0.74) HTTGAABCHEACHEMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070253957-A1 Substituted N-Aryl-1H-Pyrazolo[3,4-B]Quinolin-4-Amines and Analogs as Activators of Caspases and Inducers of Apoptosis CYTOVIA, INC. (US) 2007-11-01 US claimed
US-20070253957-A1 Substituted N-Aryl-1H-Pyrazolo[3,4-B]Quinolin-4-Amines and Analogs as Activators of Caspases and Inducers of Apoptosis CYTOVIA, INC. (US) 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070253957-A1 Substituted N-Aryl-1H-Pyrazolo[3,4-B]Quinolin-4-Amines and Analogs as Activators of Caspases and Inducers of Apoptosis CASP3, CASP7, CASP4 TP53 27/4885SMN1; SMN2 4292/4885KMT2A 2718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.